← All trials
NCT06630260
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 4, 2024
- Primary completion
- Sep 30, 2029
- Completion date
- Sep 30, 2030
- First posted
- Oct 8, 2024
- Last posted
- Nov 7, 2024
- Enrollment
- 182
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of LondonLead sponsor
- Cancer Research UKCollaborator
- Verastem, Inc.Collaborator
- National Health Service, United KingdomOfficial
- University of CambridgeCollaborator
- University of CambridgeCollaborator
- Royal Marsden Hospital NHS TrustCollaborator
- Minderoo FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.